News Release

Elsevier and the American College of Medical Genetics and Genomics announce the forthcoming launch of Genetics in Medicine Open

New gold open access journal will expand freely available content, benefiting the medical genetics and genomics community

Business Announcement

Elsevier

Bo Yuan, PhD, FACMG

image: Editor-in-Chief of GIM Open view more 

Credit: Bo Yuan

New York, October 25, 2022 – The American College of Medical Genetics and Genomics (ACMG), the only nationally recognized US medical professional organization solely dedicated to improving health through the practice of medical genetics and genomics, and Elsevier, a global leader in research publishing and information analytics, are delighted to announce the January 2023 launch of a new gold open access, online only journal: Genetics in Medicine Open (GIM Open), an Official Journal of the ACMG.

GIM Open will complement ACMG’s flagship journal Genetics in Medicine (GIM), also published by Elsevier, and is designed to meet the evolving needs of the global medical genetics and genomics community and expand its open access publishing options. Published under Creative Commons license, all GIM Open articles will be immediately, permanently, and openly available online for readers to view, download, share, and reuse. This will enable authors to more easily comply with funder and institutional mandates, even as requirements continue to evolve.

ACMG’s decision to expand the breadth of its openly available content directly supports its mission to improve personal and public health through the clinical and laboratory practice of medical genetics; advocacy, education, and clinical research programs; and the safe and effective integration of genetics and genomics into all of medicine and healthcare.

“I am excited about our new gold open access journal that will be available to anyone, anytime, anywhere in the world independent of financial resources or library access. GIM Open will be an international journal with a focus on medical genetics and genomic medicine including all aspects of therapy,” noted ACMG retiring Chief Executive Officer Maximilian Muenke, MD, FACMG, who led the development of the new journal. “It will be a trail blazer for diversity, equity, and inclusion from a double anonymous review process of manuscripts, to the Editor-in-Chief and an editorial board that truly reflects our society in the United States and around the world. We are fortunate to work with our colleagues Robert D. Steiner, MD, FAAP, FACMG, and Jan Higgins, PhD, ELS, from GIM and our publisher Elsevier on the start of this new venture. As a medical geneticist who thinks that genomic medicine is the present and future of medicine, GIM Open will educate healthcare professionals to contribute to optimal patient care everywhere.”

GIM Open’s eminent international editorial board will be led by Editor-in-Chief Bo Yuan, PhD, FACMG, Baylor College of Medicine, an internationally recognized expert in the field. “I am tremendously honored and excited to serve as the founding editor of this new journal that will actively support open science for the medical, scientific and research professionals in a broad range of specialties who comprise our ACMG community,” said Dr. Yuan. “Collectively, members of the editorial board and I are dedicated to the rapid dissemination of high quality, authoritative and cutting-edge medical genetic knowledge both within and beyond the genetics community with the ultimate goal of improving patient outcomes.”

Louise Curtis, Senior Vice President, Life Sciences and Social Sciences, Elsevier, commented, “We are extremely pleased to expand our publishing portfolio with ACMG, building on our collaborative partnership with this prestigious society that began in 2022 with publication of GIM. Launching GIM Open strongly aligns with our mission to help researchers and healthcare professionals advance science and improve health outcomes for the benefit of society, and we share the commitment to inclusion and diversity at the heart of this exciting new venture.”

GIM Open manuscript processing will include rigorous double anonymous peer review, a rapid submission to publication decision turnaround time, and an expedited publication timeline. Detailed instructions for authors and information regarding open access and publishing fees can be found here. Manuscript submission will open as of October 25, 2022. Papers submitted to GIM may be considered for publication in GIM Open if deemed more appropriate for that journal.

It is Elsevier’s intention to submit GIM Open for inclusion in the major abstracting and indexing services at the earliest opportunity.

As one of the fastest-growing open access publishers in the world, nearly all of Elsevier's 2,700 journals enable open access publishing, including 600 fully open access journals. In 2021, Elsevier published 119,000 gold or pay-to-publish open access articles, an increase of more than 46% over 2020, making Elsevier one of the largest open access publishers in the world.

 


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.